Vicore Pharma Holding AB
STO:VICO

Watchlist Manager
Vicore Pharma Holding AB Logo
Vicore Pharma Holding AB
STO:VICO
Watchlist
Price: 8.23 SEK -0.72% Market Closed
Market Cap: 1.9B SEK

Intrinsic Value

VICO's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one VICO stock under the Base Case scenario is 2.1 SEK. Compared to the current market price of 8.23 SEK, Vicore Pharma Holding AB is Overvalued by 75%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VICO Intrinsic Value
2.1 SEK
Overvaluation 75%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Vicore Pharma Holding AB

Valuation History Unavailable

Historical valuation for VICO cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Vicore Pharma Holding AB
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Vicore Pharma Holding AB

Current Assets 1.1B
Cash & Short-Term Investments 1B
Receivables 4.2m
Other Current Assets 29.2m
Non-Current Assets 1.1m
Other Non-Current Assets 1.1m
Efficiency

Free Cash Flow Analysis
Vicore Pharma Holding AB

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Vicore Pharma Holding AB

Revenue
6m SEK
Operating Expenses
-314.9m SEK
Operating Income
-308.9m SEK
Other Expenses
-3m SEK
Net Income
-311.9m SEK
Fundamental Scores

VICO Profitability Score
Profitability Due Diligence

Vicore Pharma Holding AB's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Negative 1-Year Revenue Growth
Declining ROIC
Negative Revenue Growth Forecast
15/100
Profitability
Score

Vicore Pharma Holding AB's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

VICO Solvency Score
Solvency Due Diligence

Vicore Pharma Holding AB's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
69/100
Solvency
Score

Vicore Pharma Holding AB's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VICO Price Targets Summary
Vicore Pharma Holding AB

Wall Street analysts forecast VICO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VICO is 29.49 SEK with a low forecast of 15.15 SEK and a high forecast of 40.86 SEK.

Lowest
Price Target
15.15 SEK
84% Upside
Average
Price Target
29.49 SEK
258% Upside
Highest
Price Target
40.86 SEK
397% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Vicore Pharma Holding AB
does not pay dividends
Shareholder Yield

Current shareholder yield for VICO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

VICO Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one VICO stock?

The intrinsic value of one VICO stock under the Base Case scenario is 2.1 SEK.

Is VICO stock undervalued or overvalued?

Compared to the current market price of 8.23 SEK, Vicore Pharma Holding AB is Overvalued by 75%.

Back to Top